Casein Kinase Inhibitors

CK1

CK2

Casein Kinase Inhibitors & Chemicals

Product Name	CK1	CK2	Purity
Silmitasertib		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.94%
IWP-2	CK1δ, IC₅₀: 40 nM		99.51%
Emodin		CK2α Wild-type, IC₅₀: 5.9 μM (at ATP concentration is 50 μM) CK2α Wild-type, IC₅₀: 1.4 μM (at ATP concentration is 10 μM)	99.20%
Ellagic acid		CK2, IC₅₀: 40 nM	99.23%
TID43		CK2, IC₅₀: 0.3 μM
D4476	CK1, IC₅₀: 0.3 μM		99.94%
PF-670462 dihydrochloride	CKIδ, IC₅₀: 14 nM		99.96%
Silmitasertib sodium salt		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.91%
TBB		CK2, IC₅₀: 0.15 μM (Human CK2)	99.31%
TMX-4116	CK1α		99.50%
Casein Kinase inhibitor A51	CKIα		98.58%
DMAT		CK2, IC₅₀: 0.13 μM (Human CK2)	98.09%
PF-4800567	CKIδ, IC₅₀: 711 nM		98.04%
SR-3029	CKIδ, IC₅₀: 44 nM		99.41%
FPFT-2216	CK1α		99.35%
IC261	CKIδ, IC₅₀: 1 μM CkIα1, IC₅₀: 16 μM		99.54%
TAK-715	CK1δ CK1ε		99.73%
SGC-CK2-1		CK2α, IC₅₀: 36 nM CK2α', IC₅₀: 16 nM	99.41%
CKI-7 free base	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM		99.34%
TTP 22		CK2, IC₅₀: 100 nM	98.03%
BioE-1115		CK2α, IC₅₀: 10 μM	99.56%
CK1-IN-1	CKIδ, IC₅₀: 15 nM		99.35%
AMG-548 dihydrochloride	CK1		99.91%
TA-01	CKIδ, IC₅₀: 6.8 nM		99.77%
PF-5006739	CK1δ, IC₅₀: 3.9 nM		99.56%
CK2/ERK8-IN-1		CK2, IC₅₀: 0.5 μM CK2, Ki: 0.25 μM	≥99.0%
Hematein		CKII, IC₅₀: 0.74 μM
NCC007	CKIδ, IC₅₀: 3.6 μM CKIα, IC₅₀: 1.8 μM		99.73%
MRT00033659	CKIδ, IC₅₀: 0.9 μM		99.77%
Casein Kinase inhibitor A86	CKIα		98.47%
Longdaysin	CKIδ, IC₅₀: 8.8 μM CKIα, IC₅₀: 5.6 μM		99.87%
TMX-4113	CK1α		98.66%
LH846	CKIδ, IC₅₀: 290 nM CKIα, IC₅₀: 2.5 μM		98.04%
MU1742	CKIδ		99.74%
CK2 inhibitor 2		CK2, IC₅₀: 0.66 nM	98.51%
Casein Kinase 2 Substrate Peptide		CK2	98.47%
PI-828		CK2α2, IC₅₀: 1.127 μM CK2, IC₅₀: 149 nM	99.09%
SRPIN803		CK2, IC₅₀: 203 nM	99.17%
TBCA		CK2, IC₅₀: 110 nM CK2, Ki: 77 nM	99.60%
A-3 hydrochloride	CK1, Ki: 80 μM	CK2, Ki: 5.1 μM	99.75%
BRD4/CK2-IN-1		CK2, IC₅₀: 230 nM	98.62%
AMG-548	CK1		≥99.0%
Casein kinase 1δ-IN-1	CKIδ		99.91%
LY294002 hydrochloride		CK2α2, IC₅₀: 3.869 μM CK2, IC₅₀: 0.098 μM
CK2-IN-3		CK2α, IC₅₀: 1.51 μM CK2α', IC₅₀: 7.64 μM
Quinalizarin		CK2, IC₅₀: 110 nM CK2, Ki: ~50 nM
Casein kinase 1δ-IN-3	CKIδ, pIC₅₀: 6.5376 M		99.93%
IQA		CK2
Casein kinase 1δ-IN-4	CK1δ		≥98.0%
Casein kinase 1δ-IN-15	CK1δ, IC₅₀: 0.045 μM
CK1-IN-2	CKIα, IC₅₀: 123 nM		99.54%
SR-4133	CK1δ, IC₅₀: 10 μM CK1ε, IC₅₀: 58 nM
CK2/PIM1-IN-1		CK2, IC₅₀: 3.787 μM
CK1-IN-3	CK1δ, IC₅₀: 2.22 μM		99.00%
ON 108600		CK2α2, IC₅₀: 0.005 μM CK2α1, IC₅₀: 0.05 μM	99.73%
CK2 inhibitor 3		CK2, IC₅₀: 280 nM
Ellagic acid (hydrate)		CK2, IC₅₀: 40 nM CK2, Ki: 20 nM
Casein kinase 1δ-IN-10	CK1δ
Casein kinase 1δ-IN-9	CK1δ		≥98.0%
Emodin (Standard)		CK2α Wild-type
Multi-kinase-IN-6		CK2, IC₅₀: 0.09 μM
TMCB		CK2α, Ki: 83 nM CK2α', Ki: 21 nM
CKI-7	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM
Casein Kinase II Receptor Peptide		CK2, Km: 500 μM
SR-1277	CKIδ, IC₅₀: 49 nM
AMG-548 hydrochloride	CK1
EGFR-IN-57		CK2α, IC₅₀: 0.171 μM
4,5,6,7-Tetrabromo-1H-benzimidazole		CK2
Casein kinase 1δ-IN-5	CK1δ, IC₅₀: 47 nM
(R)-DRF053 dihydrochloride	CK1, IC₅₀: 14 nM

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

站点地图隐私声明

Casein Kinase Inhibitors

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.